The Role of Lung Ultrasonography Score in Predicting Prognosis in Term and Late Preterm Newborns With Postnatal Respiratory Distress

Launched by BURSA CITY HOSPITAL · Sep 2, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how a special scoring system using lung ultrasound can help predict the health outcomes of newborns who are having trouble breathing shortly after birth. This condition, known as respiratory distress, can be caused by various factors, making it challenging for doctors to determine the exact cause in the first hour of life. The study aims to see if the lung ultrasonography score can provide valuable information to help doctors better understand and manage these newborns.

To be eligible for the trial, babies must show signs of respiratory distress right after birth, be at least 34 weeks old, weigh more than 1900 grams (about 4.2 pounds), and have family consent for participation. However, babies with certain conditions, such as congenital anomalies or heart disease, cannot take part in the study. If enrolled, participants will undergo lung ultrasounds, and doctors will monitor their breathing and overall health to see how the scoring system can assist in their care. This research is important as it may lead to improved treatment for affected newborns.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Having symptoms of respiratory distress that begin soon after birth,
• • \> 34 gestational age,
• • \>1900 gr birth weight,
• • Family consent
• Exclusion Criteria:
• • Congenital anomaly
• • Chromosomal anomaly
• • Hydrops fetalis
• • Congenital heart disease